Jean M. Petit
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of Sodium-Glucose Cotransporter 2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer.
Journal: Diabetes care
Published: August 18, 2025
Biallelic pathogenic variants in POMC can cause combined pituitary hormonal deficiency associated with severe obesity.
Journal: European journal of endocrinology
Published: April 05, 2025
Screening and management of metabolic complications of mTOR inhibitors in real-life settings.
Journal: Annales d'endocrinologie
Published: September 14, 2023
Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 09, 2022
Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes.
Journal: Age and ageing
Published: March 02, 2021
Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
Journal: Journal of diabetes science and technology
Published: February 11, 2021
Who is at risk for drug-drug interactions in type 2 diabetic patients?
Journal: Presse medicale (Paris, France : 1983)
Published: April 13, 2019
Unexpected adverse effect of metyrapone: A case report.
Journal: Clinical endocrinology
Published: April 20, 2018
Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: October 25, 2017
Last Updated: 09/26/2026